ArticleThe Journal of pharmacology and experimental therapeutics2025
Effects of Δ
Lawrence M Carey, Lindsey K Galbo-Thomma, David R Maguire, Charles P France
Abstract read
In one paragraphArticle in The Journal of pharmacology and experimental therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Lawrence M CareyDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Lindsey K Galbo-ThommaDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
David R MaguireDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Charles P FranceDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas. Electronic address: france@uthscsa.edu.
Funding
DISCRIMINATIVE STIMULUS OF OPIOID WITHDRAWALR01DA005018 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FRANCE, CHARLES P · 1988 to 2025
$8.8MTraining in Drug Abuse Research: Behavior and NeurobiologyT32DA031115 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHARLES P FRANCE · 2011 to 2026
$5.2MCannabidiol and buprenorphine: A poly-pharmacy approach to treat opioid use disorderF32DA063281 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lindsey Galbo Thomma · 2025 to 2026
$92kCannabinoid type 2 receptors as a therapeutic target for substance use disordersF32DA057804 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CAREY IV, LAWRENCE MICHAEL · 2023 to 2023
$8kNIDA NIH HHS F32 DA057804NIDA NIH HHS F32 DA063281NIDA NIH HHS L70 DA061529NIDA NIH HHS R01 DA005018NIDA NIH HHS T32 DA031115
6 · The paper itselfAbstract
The mu-opioid receptor agonists methadone and buprenorphine are effective for treating opioid use disorder (OUD); however, both drugs are diverted and misused and withdrawal signs can emerge when treatment is tapered or discontinued. Mu-opioid and cannabinoid type 1 receptors are colocalized in several brain regions, and cannabinoids have been proposed as potential treatments for opioid withdrawal. This study tested Δ
Indexed as
Behavior, AnimalCannabidiolDronabinolMorphineSubstance Withdrawal SyndromeAnimalsBlood PressureClonidineHeart RateMacaca mulattaMaleCannabidiolClonidineDronabinolMorphineCannabidiolOpioid withdrawalRhesus monkeyΔ(9)-Tetrahydrocannabinol
Identifiers
PMID40840120
PMCPMC12597650
What OpenQuestion holds
Textmetadata
Read underepoch 390